H. Res. 1265 (119th)Bill Overview

Expressing support for the designation of the week of May 3, 2026, through May 9, 2026, as "Tardive Dyskinesia Awareness Week".

domestic policy
Cosponsors
Support
Bipartisan
Introduced
May 7, 2026
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief

This House resolution expresses support for designating May 3–9, 2026, as "Tardive Dyskinesia Awareness Week" and encourages Americans to become better informed about tardive dyskinesia.

The text notes TD causes, affected populations, screening recommendations, FDA-approved treatments, and the need for monitoring by health care providers.

Passage0/100

As a House simple resolution it is non‑binding and cannot become law; adoption is likely but it does not create statutory law.

CredibilityAligned

Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the condition it seeks to highlight and precisely designates dates for an awareness week while offering a simple call to action for individuals.

Contention10/100

Liberals push for funding and coverage; conservatives prefer symbolic action only

02 · What it does

Who stands to gain, and who may push back.

Who this appears to help vs burden50% / 50%
Targeted stakeholdersFederal agencies · Manufacturers
Likely helped
  • Targeted stakeholdersMay increase public and clinician awareness, prompting more regular TD screening and recognition.
  • Targeted stakeholdersCould lead to more diagnoses and referrals, increasing treatment uptake and specialist care.
  • Targeted stakeholdersEarlier identification and treatment might reduce long-term functional impairment and related costs.
Likely burdened
  • Federal agenciesIs a symbolic, non-binding resolution that provides no federal funding or regulatory changes.
  • ManufacturersAwareness drives could increase demand for pharmaceutical treatments, benefiting manufacturers.
  • Targeted stakeholdersCould inadvertently stigmatize people taking dopamine‑blocking medications by highlighting medication-associated side e…
03 · Why people split

Why the argument around this bill splits.

Liberals push for funding and coverage; conservatives prefer symbolic action only
Progressive95%

Likely strongly supportive of awareness and of highlighting impacts on people with mental and gastrointestinal disorders.

Would welcome reduced stigma and better screening, while pushing for concrete follow-through like access and coverage for treatments.

Leans supportive
Centrist90%

Generally supportive because it is nonbinding, low-cost, and raises health awareness.

Would look for clarity that it imposes no new unfunded mandates and suggests coordination with existing public-health efforts.

Leans supportive
Conservative80%

Likely supportive of a symbolic, awareness-focused resolution but cautious about any implied federal expansion or mandates.

Prefers state, private-sector, and clinician-led responses rather than new federal programs.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood0/100

As a House simple resolution it is non‑binding and cannot become law; adoption is likely but it does not create statutory law.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether House leadership will schedule floor consideration
  • Whether a companion Senate resolution will be introduced
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberals push for funding and coverage; conservatives prefer symbolic action only

As a House simple resolution it is non‑binding and cannot become law; adoption is likely but it does not create statutory law.

Unlocked analysis

Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the condition it seeks to highlight and precisely designates dates for an awareness week while offe…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis